Not only did we validate the previously reported common NKTCL mutational targets such as STAT3, TP53, and DDX3X [7, 8, 39], we also identified a list of novel mutational targets and mutational types across both nucleotide and structure levels. The gene discussed is TP53; the disease is extranodal nasal NK/T cell lymphoma.